Abstract
The mammalian target of mTOR, a serine / threonine kinase is associated with several cellular activities. Due to the several cellular activities that are attributed to this protein, drugs have been developed inhibiting its function, the mTOR inhibitors (imTOR), represented by sirolimus, and everolimus. ImTOR are associated with severe adverse events (AE), patients on everolimus therapy mo…